成年人中度至重度脱发区域的系统治疗:最新的澳大利亚专家共识声明
Daniella Kushnir-Grinbaum1,2, Laita Bokhari3, John Frewen1
1Sinclair Dermatology, East Melbourne, Victoria, Australia.
The Australasian journal of dermatology
|September 30, 2025
概括
此更新包含新的Janus激酶抑制剂 (JAKi) 用于治疗严重的脱发区 (AA). 它为澳大利亚的慢性,中度至重度AA使用这些JAK抑制剂提供了指导.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 每年有超过5000名澳大利亚人患有白发性脱发症 (AA),慢性形式进展为严重脱发.
- 目前慢性,中度至重度AA的治疗方法有限,影响患者的生活质量.
- 雅努斯激酶抑制剂 (JAKi) 显示为AA的全身治疗有前途.
研究的目的:
- 更新2018年澳大利亚专家的共识,治疗慢性,中度至严重的AA.
- 整合TGA批准的新的Janus激酶抑制剂 (JAKi) 的指导.
- 为AA提供关于JAKi启动,管理和停止的建议.
主要方法:
- 2018年澳大利亚专家共识声明的审查和增强.
- 包括TGA批准的JAK抑制剂 (巴里西提尼布,里特利西提尼布) 用于严重的AA.
- 制定JAKi治疗指示,结果和中止的指导方针.
主要成果:
- 2025年更新将JAK抑制剂纳入AA治疗算法.
- 提供了关于启动,继续和定位JAKi治疗的指导.
- 讨论了成功/失败治疗和停止治疗的标准.
结论:
- 新的JAK抑制剂在澳大利亚治疗严重的AA方面取得了重大进展.
- 这一更新的共识为临床医生管理慢性AA提供了必要的指导.
- 预计PBS上JAK抑制剂的补偿将改变AA治疗的可访问性.
相关概念视频
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824
Nephrotic Syndrome II : Assessment and Medical Management
201
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
201


